Unibest

Pharmaceutical intermediates

Ipatacopan Hydrochloride Intermediates

6 pharmaceutical intermediates for Ipatacopan Hydrochloride. Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH).

提交项目All intermediates

About Ipatacopan Hydrochloride

Originator
Novartis Pharmaceuticals Corp
Indication
Paroxysmal Nocturnal Hemoglobinuria (PNH)

Available intermediates

6 intermediates currently listed for Ipatacopan Hydrochloride. Request specifications, documentation or a quotation for any item below.

Ipatacopan Hydrochloride intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
tert-Butyl5-methoxy-7-methyl-1H-indole-1-carboxylate1387445-50-2//
tert-Butyl 4-formyl-5-methoxy-7-methyl-1Hindole-1-carboxylate1481631-51-9//
tert-butyl 4-formyl-5-hydroxy-7-methyl-1Hindole-1-carboxylate2408761-23-7//
1H-Indole-1-carboxylic acid, 5-hydroxy-7-methyl-, 1,1-dimethylethyl ester2408761-22-6//
methyl4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate1644667-61-7//
Benzoic acid, 4-[(2R,4R)-4-ethoxy-2-piperidinyl]-, methyl ester, rel-1644667-62-8//

Other programs under I

Ibrutinib/ Zanubrutinib IguratimodImatinibImeglimin hydrochlorideIndacaterol MaleateInfigratinibIpragliflozinIrinotecan

Building toward Ipatacopan Hydrochloride?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →